Cornerstone Pharma Raises $6 Million

Cornerstone Pharmaceuticals Inc., a drug development company focused on cancer bioenergetics, has raised $6 million in new angel funding. It has offices in both Stony Brook, N.Y. and Cranbury, New Jersey.

North AmericaUSBriefs